ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

ONS Forms More Special Interest Groups For Members

May 11, 1990

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977